Search by Drug Name or NDC

    NDC 60505-6128-01 Irinotecan Hydrochloride 20 mg/mL Details

    Irinotecan Hydrochloride 20 mg/mL

    Irinotecan Hydrochloride is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp.. The primary component is IRINOTECAN HYDROCHLORIDE.

    Product Information

    NDC 60505-6128
    Product ID 60505-6128_a6ea9cfb-560c-4601-a774-70d2e85ed04c
    Associated GPIs 21550040102025 21550040102030
    GCN Sequence Number 062173
    GCN Sequence Number Description irinotecan HCl VIAL 40 MG/2 ML INTRAVEN
    HIC3 V3E
    HIC3 Description ANTINEOPLASTIC - TOPOISOMERASE I INHIBITORS
    GCN 97955
    HICL Sequence Number 010778
    HICL Sequence Number Description IRINOTECAN HCL
    Brand/Generic Generic
    Proprietary Name Irinotecan Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Irinotecan Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 20
    Active Ingredient Units mg/mL
    Substance Name IRINOTECAN HYDROCHLORIDE
    Labeler Name Apotex Corp.
    Pharmaceutical Class Topoisomerase Inhibitor [EPC], Topoisomerase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA203380
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-6128-01 (60505612801)

    NDC Package Code 60505-6128-1
    Billing NDC 60505612801
    Package 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128-1) / 5 mL in 1 VIAL, SINGLE-USE
    Marketing Start Date 2017-11-30
    NDC Exclude Flag N
    Pricing Information N/A